Revvity
Immacolata Porreca is an experienced researcher in the field of genetics and biotechnology, currently serving as an R&D Manager at Revvity since May 2023. Prior roles include R&D Manager at Horizon Discovery, where responsibilities encompassed both managerial and scientific roles, and Postdoctoral Researcher at Wellcome Sanger Institute, where research focused on HIV viral control mechanisms. Immacolata has also held postdoctoral positions at Biogem, where projects involved mammalian cultures and environmental toxicants, and was a visiting Research Scientist at Karlsruher Institut für Technologie, applying CRISPR/CAS9 technology. Educational qualifications include a PhD in Human Genetics and multiple degrees in Biotechnology from the University of Naples Federico II. As a first author, Immacolata has contributed to significant publications in Developmental Biology.
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com